Insurance Premiums Should Help Support Coverage Policy Research – CMS
This article was originally published in The Gray Sheet
Executive Summary
Large payers and purchasers of healthcare technology should set aside 1% of their income through insurance premiums to help fund research geared towards improving reimbursement policy, according to CMS' Sean Tunis
You may also be interested in...
CAD/Digital Mammography Capabilities Will Inform IoM Breast Cancer Report
Computer-aided detection integrated with full-field digital mammography will soon become routine for breast cancer screening and may be widely accepted by clinicians for diagnostic use, according to University of Chicago radiology professor Maryellen Giger, PhD
PET Cancer Coverage Decision Saves Dense-Breast Indication For Another Day
The Centers for Medicare & Medicaid Services is inviting interested parties to submit a separate coverage request for FDG-PET in women who have dense breast tissue
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.